Medical Advisory Board
Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.
Search results
Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.
Many inherited sight loss conditions occur when cells in the retina, which is the light-sensitive region at the back of the eye, deteriorate in an unpredictable way. These conditions are often referred to as inherited retinal dystrophies.
Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Different inherited sight loss conditions present noticeable symptoms at different times.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
A general overview of the clinical trials process and practicalities, including issues to consider if you are given the opportunity to take part.
CRISPR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows.
This time we are joined by Roly Megaw, Clinical Lecturer and Honorary Consultant Ophthalmologist at University of Edinburgh and NHS Lothian
Our partnerships are mutually beneficial. For Retina UK this means we can fund more research and offer support on a local level, while our partners can achieve corporate social responsibility objectives whilst making a tangible impact.